Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Debt to Equity (2016 - 2017)

Lisata Therapeutics' Debt to Equity history spans 8 years, with the latest figure at $0.01 for Q2 2017.

  • For Q2 2017, Debt to Equity fell 99.47% year-over-year to $0.01; the TTM value through Jun 2017 reached $0.01, down 99.47%, while the annual FY2016 figure was $1.39, 115.75% up from the prior year.
  • Debt to Equity reached $0.01 in Q2 2017 per LSTA's latest filing, up from -$3.87 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.56 in Q2 2016 to a low of -$3.87 in Q1 2017.
  • Average Debt to Equity over 5 years is $0.1, with a median of $0.12 recorded in 2016.
  • Peak YoY movement for Debt to Equity: surged 1832.96% in 2015, then plummeted 3267.99% in 2017.
  • A 5-year view of Debt to Equity shows it stood at $0.0 in 2013, then skyrocketed by 870.03% to $0.03 in 2014, then soared by 1832.96% to $0.64 in 2015, then skyrocketed by 115.75% to $1.39 in 2016, then crashed by 99.4% to $0.01 in 2017.
  • Per Business Quant, the three most recent readings for LSTA's Debt to Equity are $0.01 (Q2 2017), -$3.87 (Q1 2017), and $1.39 (Q4 2016).